Sapporo, Japan

Tomoko Shimizu



 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hokkaido, JP (2014 - 2016)
  • Sapporo, JP (2015 - 2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tomoko Shimizu

Introduction

Tomoko Shimizu is a prominent inventor based in Sapporo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting human receptors. With a total of five patents to her name, her work has the potential to impact medical treatments and therapeutic approaches.

Latest Patents

One of her latest patents involves an antibody against the human prostaglandin E2 receptor EP4. The objective of this invention is to provide an antibody that binds to the human PGE receptor subtype EP4 and inhibits its function. Additionally, it aims to offer a medicament that comprises this antibody or a functional fragment thereof. The research involved immunizing mice with the human PGE receptor subtype EP4 and screening for a monoclonal antibody that suppresses the intracellular cAMP level increase induced by EP4. The CDR sequences of the obtained monoclonal antibody were also determined, showcasing the depth of her research.

Career Highlights

Throughout her career, Tomoko Shimizu has worked with notable companies such as Nb Health Laboratory Co., Ltd. and Sekisui Chemical Co., Ltd. Her experience in these organizations has contributed to her expertise in the field of biotechnology and innovation.

Collaborations

Tomoko has collaborated with esteemed colleagues, including Kiyoshi Takayama and Yuji Urushibata. These partnerships have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Tomoko Shimizu's innovative work in developing antibodies against human receptors exemplifies her significant contributions to biotechnology. Her patents and collaborations reflect her dedication to advancing medical science and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…